medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2015, Number 4

<< Back Next >>

An Med Asoc Med Hosp ABC 2015; 60 (4)

Gastrointestinal manifestations in children with autism spectrum disorder

Casaubon GPR, Goldbard RD

Language: Spanish
References: 31
Page: 266-272
PDF size: 217.01 Kb.


ABSTRACT

Introduction: Autism spectrum disorder is a group of developmental disabilities that can cause significant social, communication and behavioral problems. It has a prevalence of approximately 1% of the population. Currently, it has been proved that there is an abnormal brain development, with a complex interaction between genetic predisposition and environmental factors. Objective: Since there is a higher incidence of TEA in the world, pediatricians should have knowledge of the gastrointestinal pathology in these patients. The most common gastrointestinal manifestations reported in various series are flatulence (60%), bloating (37%) and abdominal pain (37%). Conclusions: Knowing the most common gastrointestinal problems in this group of patients allows an appropriate and timely treatment, often improving the intensity of the behavioral disorders in some of these patients.


REFERENCES

  1. Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network. United States; 2008. [Fecha de consulta: diciembre 2014]. Available in: www.cdc.gov/ncbddd/autism/documents/ADDM-2012-Community-Report.pdf

  2. Rosenblatt AI, Carbone PS, Winnie Y. Expert guidance from the American Academy of Pediatrics. Autism Spectrum Disorders: What every parent needs to know. Illinois: American Academy of Pediatrics; 2013.

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.

  4. DiGuiseppi C, Hepburn S, Davis JM, Fidler DJ, Hartway S, Lee NR et al. Screening for autism spectrum disorders in children with Down syndrome. J Dev Behav Pediatr. 2010; 31: 181-191.

  5. Cohen D, Pichard N, Tordjman S, Baumann C, Burglen L, Excoffier E et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord. 2005; 35 (1): 103-116.

  6. Hall SS, Lightbody AA, Reiss AL. Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Am J Ment Retard. 2008; 113 (1): 44-53.

  7. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009; 163 (10): 907-914.

  8. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011; 68 (11): 1095-1102.

  9. Ronald A, Happe F, Bolton P, Butcher LM, Price TS, Wheelwright S et al. Genetic heterogeneity between the three components of the autism spectrum: A twin study. J Am Acad Child Adolesc Psychiatry. 2006; 45 (6): 691-699.

  10. Taniai H, Nishiyama T, Miyahci T, Imaeda M, Sumi S. Genetic influences on the broad spectrum of autism: study of proband-ascertained twins. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B (6): 844-849.

  11. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics. 2011; 128: e488-e495.

  12. Sumi S, Taniai H, Miyachi T, Tanemura M. Sibling risk of pervasive developmental disorder estimated by means of an epidemiologic survey in Nagoya, Japan. J Hum Genet. 2006; 51: 518-522.

  13. Horvath K, Papadimitriou J, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999; 135 (5): 559-563.

  14. Horvath K, Perman J. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr. 2002; 14: 583-587.

  15. McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014; 133: 872-883.

  16. Levy S, Hyman S. Complementary and alternative medicine treatments for children with autism spectrum disorder. Child Adolesc Psychiatr Clin N Am. 2008; 17 (4): 801-816.

  17. Zecavati N, Spence SJ. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep. 2009; 9 (2): 129-136.

  18. Buie T, Fuchs GJ 3rd, Furuta GT, Kooros K, Levy J, Lewis JD et al. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics. 2010; 125: S19-S29.

  19. De Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010; 51 (4): 418-424.

  20. Wakefield AJ. The gut-brain axis in childhood developmental disorder. JPGN. 2002; 34: S14-S17.

  21. Indrio F, Riezzo G, Raimondi F, Di Mauro A, Francavilla R. Microbiota involvement in the gut-brain axis. JPGN. 2013; 57 (1): S11-S14.

  22. Foster JA, McVey-Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36 (5): 305-312.

  23. Williams BL, Hornig M, Buie T, Bauman ML, Cho-Paik M, Wick I et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011; 6 (9): e24585.

  24. Williams BL, Hornig M, Parekh T, Lipkin WI. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio. 2012; 3 (1): e00261-11.

  25. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007; 176: 149-169.

  26. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci. 2011; 108: 16050-16055.

  27. Terrin G, Passariello A, Berni-Canani B. Drugs and tight junctions: adverse effects and opportunities for new therapeutic approaches. JPGN. 2012; 54 (2): 444-445.

  28. Piche T. Tight junctions and IBS-the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014; 26 (3): 296-302.

  29. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013; 70 (4): 631-659.

  30. Jauregi A, Fernandez N, Irastorza I, Plaza-Izurieta L, Victoria JC, Bilbao JR. Alteration of tight junction gene expression in celiac disease. JPGN. 2014; 58 (6): 762-767.

  31. Högberg N, Stenbäck A, Carlsson PO, Wanders A, Lilja HE. Genes regulating tight junctions and cell adhesion are altered in early experimental necrotizing enterocolitis. J Pediatr Surg. 2013; 48: 2308-2312.




2020     |     www.medigraphic.com